CLGN
Collplant Biotechnologies Ltd
A maker of regenerative and aesthetic medicine products, CollPlant grows human collagen in tobacco plants by engineering them with human genes, then turns it into medical materials like its Collink.3D bioinks used for 3D bioprinting tissues and organs, and even 3D-printed regenerative breast implants. Founded in 2004 in Rehovot, Israel, by scientist Oded Shoseyov, the company's name is a play on its product — plant-based collagen. The quirk: it uses tobacco, a plant better known for cigarettes, to grow the building blocks of human tissue.
ISIN: IL0004960188HealthcareIL1 holder
Total Value
$2.40M
Total Shares
241.4K
Net Share Change
+5.7K
Activity
1 buying
Investor
Value
Shares
Weight
Change
